Uracle Co., Ltd.

As of June 30, 2026, Uracle Co., Ltd. carries a market capitalization of 27.67B, placing it among publicly traded companies globally. Its enterprise value stands at 28.85B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Uracle Co., Ltd. has 3.93M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.71, and the price-to-book ratio stands at 1.59.

These figures are as of June 30, 2026. The EV/Sales ratio of 0.74 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 28.85B versus a market cap of 27.67B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Uracle Co., Ltd. maintains a current ratio of 3.23, meaning it holds 3.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 26.62, indicating elevated leverage, while an interest coverage ratio of -42.29 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Uracle Co., Ltd. posted a negative return on equity (ROE) of -31.87, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -17.45, reflecting losses generated across the asset base. The company generates approximately 162.82M in revenue per employee across its workforce of 240.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 41.60 indicates how many times Uracle Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Uracle Co., Ltd. recorded an income tax benefit of -33.10M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -6.62B and -6.59B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, Uracle Co., Ltd.'s stock has declined approximately 61.21% over the past 52 weeks. The 50-day moving average sits at 6,636.60, while the 200-day moving average is 9,888.75.

Over the twelve months ended June 30, 2026, Uracle Co., Ltd. generated 39.16B in revenue and converted that into -6.59B in net income, yielding earnings per share of -1,676.77. EBITDA reached -3.99B, while operating income came in at -6.45B.

As of June 30, 2026, Uracle Co., Ltd. holds 3.47B in cash and equivalents against 4.65B in total debt, resulting in a net debt position of -2.77B. Total book value stands at 17.46B, with working capital of 14.64B providing operational flexibility.

Uracle Co., Ltd. produced -7.88B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1.80B in capital expenditures, free cash flow totaled -9.68B - equivalent to -2,462.46 per share.

Over the twelve months ended June 30, 2026, Uracle Co., Ltd. posted a gross margin of 16.16, reflecting its pricing power and cost economics. The operating margin of -16.47 and net profit margin of -16.83 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Uracle Co., Ltd. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -34.98: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 4.28, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Uracle Co., Ltd. shareholders.

As of June 30, 2026, Uracle Co., Ltd. has an Altman Z-Score of 2.44, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.